Patent Assignment
Reel/Frame 013868/0759
Assignment of Assignor's Interest
Recorded: 2003-03-27
Pages: 3
Assignor
SUNTORY LIMITED
Executed: 2003-03-14
Assignee
DAIICHI SUNTORY PHARMA CO., LTD.
7-2 KOJIMACHI 5-CHOME, CHIYODA-KU, TOKYO, JAPAN
Covered Properties
(82)
Pharmaceutical Composition for the Treatment of Infantile Autism
Patent:
4,778,794 →
Application:
06/870,495 →
Novel Host E. Coli and Use Thereof
Patent:
4,874,697 →
Application:
06/947,398 →
Human B-Cell Differentiation Factor and Process of Producing Said Factor
Patent:
5,324,640 →
Application:
07/099,467 →
Use of a 97 Amino Acid Leader Sequence from the E. Coli B-Galactosidase Gene for the Production of -Hanp and Hptc as Fusion Protein
Patent:
4,987,070 →
Application:
07/163,548 →
Pharmaceutical Composition and Method for the Treatment of Infantile Autism
Patent:
4,920,122 →
Application:
07/210,312 →
Benzoxazepine Derivative
Patent:
5,071,845 →
Application:
07/454,273 →
Penem Compounds and Use Thereof
Patent:
4,997,829 →
Application:
07/496,145 →
Process for Preparing Optically Active 3-Hydroxybutane Derivatives Using Lipase
Patent:
5,128,264 →
Application:
07/565,959 →
Pyrroloazepine Derivatives
Patent:
5,206,239 →
Application:
07/651,778 →
Oral Antibacterial Compositions and Method for the Improvement of Gastrointestinal Absorption of Penem or Carbapenem Antibiotics
Patent:
5,354,748 →
Application:
07/828,571 →
Penem Compounds
Patent:
5,703,068 →
Application:
07/971,827 →
Antibacterial Penem Compounds
Patent:
5,506,225 →
Application:
07/971,828 →
Antibacterial Penem Esters Derivatives
Patent:
5,830,889 →
Application:
07/971,829 →
Pyrroloazepine Derivatives
Patent:
5,391,731 →
Application:
07/987,703 →
Pyrroloazepine Derivative
Patent:
5,397,780 →
Application:
08/030,268 →
Pyrroloazepine Compound
Patent:
5,399,557 →
Application:
08/030,427 →
Method for Inhibiting Metastasis of Colon Cancer to the Liver
Patent:
5,648,078 →
Application:
08/129,195 →
Anti-Hbs Antibody Genes and Expression Plasmids Therefor
Patent:
5,808,032 →
Application:
08/157,101 →
Pyrroloazepine Derivatives
Patent:
5,416,082 →
Application:
08/195,019 →
Human B-Cell Differentiation Factor and Process of Producing Said Factor
Patent:
5,530,098 →
Application:
08/257,525 →
Pharmaceutical Composition for Treatment of Adult Respiratory Distress Syndrome Containing Human Anp
Patent:
5,418,219 →
Application:
08/279,075 →
Oxidized Phospholipid Degrading Enzyme and Gene Thereof
Patent:
5,849,557 →
Application:
08/283,917 →
Process for Preparing Optically Active Alpha-Hydroxyalkene Derivatives
Patent:
5,637,500 →
Application:
08/311,885 →
Process for Producing Peptides in E.Coli
Patent:
5,670,340 →
Application:
08/352,179 →
Suppressant of Corneal Subepithelial Clouding
Patent:
5,585,354 →
Application:
08/404,150 →
Oral Antibacterial Compositions and Method for the Improvement of Gastrointestinal Absorption of Penem or Carbapenem Antibiotics
Patent:
5,637,612 →
Application:
08/425,223 →
Method for Controlling Gene Expression
Patent:
5,622,840 →
Application:
08/456,923 →
Antibacterial Penem Esters Derivatives
Patent:
5,885,981 →
Application:
08/470,944 →
Antibodies Specific for Megakaryocyte Differentiation Factor
Patent:
5,831,030 →
Application:
08/472,659 →
Dna Encoding Megakaryocyte Differentiation Factor
Patent:
5,874,253 →
Application:
08/474,661 →
Process for Production of Protein
Patent:
6,037,145 →
Application:
08/523,373 →
Synthetic Method of Hymenialdisine and Its Derivatives and Their Synthetic Intermediates, and Those Synthetic Intermediates
Patent:
5,621,099 →
Application:
08/586,638 →
Megakaryocyte Differentiation Factor
Patent:
5,972,886 →
Application:
08/611,977 →
Imidazolidine Derivative and Use Thereof
Patent:
5,691,335 →
Application:
08/615,277 →
Method for Treating Spinocerebellar Degeneration
Patent:
5,753,656 →
Application:
08/632,412 →
Mutant Staphylococcus Aureus V8 Proteases
Patent:
5,747,321 →
Application:
08/657,192 →
Thiopyran Derivatives
Patent:
5,977,111 →
Application:
08/667,713 →
Benzothiazine Derivative
Patent:
5,874,429 →
Application:
08/669,615 →
Remedy for Prurigo
Patent:
5,972,365 →
Application:
08/709,093 →
Medicament for the Alleviation or Treatment of Symptom Derived from Ischemic Disease and Compound Useful Therefor
Patent:
6,048,876 →
Application:
08/714,104 →
Novel Method for Animal Cell Culture
Patent:
5,976,833 →
Application:
08/716,533 →
Arylpiperidine and Arylpiperazine Derivatives and Medicament Containing the Same
Patent:
5,723,475 →
Application:
08/732,284 →
Process for Preparing 1-Substituted Pyrrole-3-Carboxylic Acid Derivatives
Patent:
5,684,161 →
Application:
08/741,911 →
Process for Production of Protein
Patent:
5,834,249 →
Application:
08/759,945 →
Process for Production of Secretory KEX2 Derivatives
Patent:
5,885,821 →
Application:
08/805,918 →
Method for Culturing Microorganisms Having Methanol Metabolic Pathway
Patent:
6,171,828 →
Application:
08/811,024 →
Method for Cleaving Chimeric Protein Using Processing Enzyme
Patent:
5,891,671 →
Application:
08/811,028 →
Cyclopropachromencarboxylic Acid Derivatives
Patent:
5,843,988 →
Application:
08/817,389 →
Quinazoline Derivatives and Applications Thereof
Patent:
5,814,631 →
Application:
08/849,114 →
Therapeutics for Thrombocytopenia
Patent:
6,040,335 →
Application:
08/849,887 →
Production Method of Optically Active Trans-Vinylsulfide Alcohol
Patent:
6,049,009 →
Application:
08/860,563 →
Pyrroloazepine Derivatives
Patent:
5,962,448 →
Application:
08/875,495 →
Platelet Activating Factor Acetylhydrolase, and Gene Thereof
Patent:
5,880,273 →
Application:
08/886,152 →
1'S 5R, 6R-Carbapenem Derivatives and Antimicrobial Agents Comprising the Same
Patent:
6,051,569 →
Application:
08/911,937 →
Protein Inhibiting the Growth of Human Endometrial Fibroblasts
Patent:
5,932,700 →
Application:
08/920,872 →
Oxidized Phospholipid Degrading Enzyme and Gene Thereof
Patent:
5,880,272 →
Application:
08/961,716 →
Arylpiperidinol and Arylpiperidine Derivatives and Drugs Containing the Same
Patent:
6,455,549 →
Application:
09/043,563 →
Method for Screening Compounds Regulating the Expression of Human-Inducible Nitric Oxide Synthase
Patent:
6,203,982 →
Application:
09/068,880 →
Pyrroloazepine Compounds
Patent:
6,187,772 →
Application:
09/147,248 →
Benzothiazine Derivative
Patent:
6,001,827 →
Application:
09/192,287 →
Platelet Activating Factor Acetylhydrolase, and Gene Thereof
Patent:
6,323,017 →
Application:
09/196,222 →
Method of Production and Method of Separation of 2,4'-Dipyridyl Derivatives and Methods of Production of Benzoxazepine Derivatives and Salts Thereof
Patent:
6,096,884 →
Application:
09/230,168 →
Process of Production of 4-Substituted-3-Halogeno-1,4-Benzoxazepine Derivative and Salts Thereof
Patent:
6,114,522 →
Application:
09/254,719 →
Method for Screening Substance Inhibiting Activation of Nf-Kappa B
Patent:
6,156,516 →
Application:
09/272,706 →
1-Aryl-1,8-Naphthylidin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor
Patent:
6,297,248 →
Application:
09/284,019 →
Benzoxazepine Derivatives and Their Salts and Medicaments Containing the Same
Patent:
6,187,769 →
Application:
09/306,995 →
Pyrroloazepine Derivatives
Patent:
6,258,805 →
Application:
09/312,713 →
Arylpiperidinopropanol and Arylpiperazinopropanol Derivatives and Pharmaceuticals Containing the Same
Patent:
6,407,099 →
Application:
09/331,712 →
Thiopyran Derivatives
Patent:
6,100,265 →
Application:
09/353,773 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Patent:
6,271,223 →
Application:
09/367,841 →
Pyrrolothiazine and Pyrrolothiazepine Compounds Having Serotonin-2 Receptor Antagonistic and Alpha-1-Blocking Action
Patent:
6,331,623 →
Application:
09/367,842 →
Benzothiazine Derivative
Patent:
6,316,442 →
Application:
09/379,853 →
Antibacterial Composition for Topical Administration Containing Antibiotic
1-Cycloalkyl-1,8-Naphthyridin-4-One Derivative as Type Iv Phosphodiesterase Inhibitor
Patent:
6,331,548 →
Application:
09/402,142 →
Prophylactic or Therapeutic Agents for Drug-Induced Renal Injury
Patent:
6,288,067 →
Application:
09/427,550 →
Prophylactic or Therapeutic Agents for Diseases Haivng Vascular Dysfunction Associated with Insulin Resistance
Thiopyran derivatives
Patent:
6,294,677 →
Application:
09/531,141 →
Medicament for the Alleviation or Treatment of Symptom Derived from the Ischemic Disease and Compound Useful Therefor
Patent:
6,469,010 →
Application:
09/532,934 →
Pyrroloazepine compounds
Patent:
6,211,362 →
Application:
09/640,010 →
Intermittent claudication therapeutic drugs comprising pyrroloazepines
Patent:
6,288,056 →
Application:
09/673,514 →
Pyrimidine Derivatives and Their Salts, Useful for Making Benzoxazepine Derivatives
Patent:
6,337,397 →
Application:
09/726,481 →
Pyrroloazepine Derivatives
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Jun 4, 1986
From: WATANABE, YASUGOSHI; NARUSE, HIROSHI; TAKESADA, MASASHI; HAYAISHI, OSAMU
To: SUNTORY LIMITED
Reel/Frame 004571/0480 →
Assignment of Assignors Interest.
Jan 15, 1988
From: HONJO, TASUKU; TAKATSU, KIYOSHI; SEVERINSON, EVA
To: SUNTORY LIMITED
Reel/Frame 004843/0920 →
Assignment of Assignors Interest.
Jun 7, 1988
From: MAGOTA, KOJI; OSHIMA, TAKEHIRO; TANAKA, SHOJI
To: SUNTORY LIMITED
Reel/Frame 004894/0007 →
Assignment of Assignors Interest.
Feb 14, 1990
From: TATSUOKA, TOSHIO; NOMURA, KAYOKO; SHIBATA, MAKOTO
To: SUNTORY LIMITED
Reel/Frame 005247/0588 →
Assignment of Assignors Interest.
Apr 27, 1992
From: SIH, CHARLES J.
To: SUNTORY LIMITED
Reel/Frame 006094/0118 →
Assignment of Assignors Interest.
Jan 7, 1993
From: MIZUNO, AKIRA; CHO, HIDETSURA; HAMAGUCHI, MIKIKO; TATSUOKA, TOSHIO
To: SUNTORY LIMITED
Reel/Frame 006369/0578 →
Assignment of Assignor's Interest
Jul 22, 1993
From: MIZUNO, AKIRA; CHO, HIDETSURA; MIYA, MIKIKO; TATSUOKA, TOSHIO
To: SUNTORY LIMITED
Reel/Frame 006615/0209 →
Assignment of Assignor's Interest
Jul 23, 1993
From: MIZUNO, AKIRA; MIYA, MIKIKO; INOMATA, NORIO; TATSUOKA, TOSHIO
To: SUNTORY LIMITED
Reel/Frame 006615/0358 →
Assignment of Assignor's Interest
Jul 23, 1993
From: IWATA, HIROMITSU; NAKATSUKA, TAKASHI; TANAKA, RIE; ISHIGURO, MASAJI
To: SUNTORY LIMITED
Reel/Frame 006621/0041 →
Assignment of Assignor's Interest
Aug 4, 1993
From: IWATA, HIROMITSU; NAKATSUKA, TAKASHI; TANAKA, RIE; ISHIGURO, MASAJI
To: SUNTORY LIMITED
Reel/Frame 006635/0501 →
Assignment of Assignor's Interest
Oct 14, 1993
From: IWATA, HIROMITSU; NAKATSUKA, TAKASHI; TANAKA, RIE; ISHIGURO, MASAJI
To: SUNTORY LIMITED
Reel/Frame 006723/0752 →
Assignment of Assignor's Interest
Apr 11, 1994
From: KURIHARA, TATSUYA; MATSUKURA, SHIGEKAZU; TSURUOKA, NOBUO; ARIMA, KENJI
To: SUNTORY LIMITED
Reel/Frame 007079/0789 →
Assignment of Assignor's Interest
May 11, 1994
From: HASHINO, JUNKO; OIKAWA, SHINZO; NAKAZATO, HIROSHI; NAKANISHI, TOSHIHIRO
To: SUNTORY LIMITED
Reel/Frame 006992/0310 →
Assignment of Assignor's Interest
Jun 10, 1994
From: SUGITA, OSAMU; KANAI, YASUSHI; KOJIMA, TAKUMI
To: SUNTORY LIMITED
Reel/Frame 007015/0920 →
Assignment of Assignor's Interest
Mar 3, 1995
From: ADACHI, HIDEKI; TSUJIMOTO, MASAFUMI; INOUE, KEIZO; ARAI, HIROYUKI
To: SUNTORY LIMITED
Reel/Frame 007378/0524 →
Assignment of Assignor's Interest
Feb 28, 1997
From: SIH, CHARLES J.
To: SUNTORY LIMITED
Reel/Frame 008372/0538 →
Change of Name
Dec 9, 2005
From: DAIICHI SUNTORY PHARMA CO., LTD.
To: DAIICHI ASUBIO PHARMA CO., LTD.
Reel/Frame 016871/0277 →
Address Change
Dec 22, 2005
From: DAIICHI ASUBIO PHARMA CO., LTD.
To: DAIICHI ASUBIO PHARMA CO., LTD.
Reel/Frame 016926/0784 →
Change of Name
May 29, 2007
From: DAIICHI ASUBIO PHARMA CO., LTD.
To: ASUBIO PHARMA CO., LTD.
Reel/Frame 019341/0642 →